インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ジャーナル目次
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
このページをシェアする
ジャーナルチラシ
Flyer image

概要

Assessment of a Key Message in Newly Diagnosed Type 2 Diabetes Mellitus Patients Considering Their Educational Program

Ciprian Constantin and Aurelian Ranetti

Background: It is well known that therapeutic nutrition education provided to patients with new diagnosed type 2 diabetes mellitus is crucial in terms of subsequent adherence to a dedicated multi-factorial treatment. The patient could be empowered to act on insulin dose and/or on other aspects (calorie intake, therapeutically efforts and sleep schedule etc.) regarding the achievement of the final therapeutic targets.

Objective: The aim of this retrospective study was to determine the impact of the message perceived by patients with new diagnosed type 2 diabetes mellitus on the means used in achieving metabolic control at 3 months of treatment after an initial educational program.

Method: We performed a retrospective, case-control study of 143 patients with new diagnosed type 2 diabetes mellitus patients admitted to general hospital wards to investigate the relationship between remaining messages after attending our educational program with all methods to achieve adequate metabolic control. It was hypothesized that message have a great impact considering all methods to achieve this targets and are associated with a greater impact of dose insulin.

Result: At the moment of evaluation we find that the dose of insulin is significantly different between the two lots: 0.43 ± 0.02 UI/Kgc vs. 0.13 ± 0.01 UI/Kgc, p <0.05; and the level of physical therapeutic effort is also significantly different 2.12 ± 0.35 MET/day vs. 3.51 ± 0.32 MET/day, p<0.05. At the same time weight loss, as well as HbA1c levels that the groups reached, have statistical significance (p<0.05).

Conclusion: We could say at the final of our study that the main message of our program is associated with a lower dose of insulin used for treatment of type 2 diabetes mellitus patients.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません